• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于蛋白质结构的药物设计:从对接至分子动力学。

Protein structure-based drug design: from docking to molecular dynamics.

机构信息

Department of Biochemistry, University of Zurich, Winterthurerstr. 190, 8057 Zürich, Switzerland.

出版信息

Curr Opin Struct Biol. 2018 Feb;48:93-102. doi: 10.1016/j.sbi.2017.10.010. Epub 2017 Nov 14.

DOI:10.1016/j.sbi.2017.10.010
PMID:29149726
Abstract

Recent years have witnessed rapid developments of computer-aided drug design methods, which have reached accuracy that allows their routine practical applications in drug discovery campaigns. Protein structure-based methods are useful for the prediction of binding modes of small molecules and their relative affinity. The high-throughput docking of up to 10 small molecules followed by scoring based on implicit-solvent force field can robustly identify micromolar binders using a rigid protein target. Molecular dynamics with explicit solvent is a low-throughput technique for the characterization of flexible binding sites and accurate evaluation of binding pathways, kinetics, and thermodynamics. In this review we highlight recent advancements in applications of ligand docking tools and molecular dynamics simulations to ligand identification and optimization.

摘要

近年来,计算机辅助药物设计方法发展迅速,其准确性已经达到了可以在药物发现项目中常规应用的程度。基于蛋白质结构的方法可用于预测小分子的结合模式及其相对亲和力。通过对多达 10 个小分子进行高通量对接,然后根据隐式溶剂力场进行评分,可以使用刚性蛋白质靶标可靠地识别出具有微摩尔结合能力的配体。使用显式溶剂的分子动力学是一种低通量技术,可用于描述柔性结合位点,并准确评估结合途径、动力学和热力学。在这篇综述中,我们重点介绍了配体对接工具和分子动力学模拟在配体鉴定和优化方面的最新应用进展。

相似文献

1
Protein structure-based drug design: from docking to molecular dynamics.基于蛋白质结构的药物设计:从对接至分子动力学。
Curr Opin Struct Biol. 2018 Feb;48:93-102. doi: 10.1016/j.sbi.2017.10.010. Epub 2017 Nov 14.
2
NMR in structure-based drug design.基于结构的药物设计中的 NMR。
Essays Biochem. 2017 Nov 8;61(5):485-493. doi: 10.1042/EBC20170037.
3
Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.对接和分子动力学模拟在配体-受体相互作用和结构-功能关系方面的进展。
Curr Top Med Chem. 2018;18(20):1755-1768. doi: 10.2174/1568026618666181025114157.
4
Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.NRGsuite和分子对接软件FlexAID在计算机辅助药物发现与设计中的应用。
Methods Mol Biol. 2018;1762:367-388. doi: 10.1007/978-1-4939-7756-7_18.
5
Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.药物发现中的相对结合自由能计算:最新进展与实际考虑。
J Chem Inf Model. 2017 Dec 26;57(12):2911-2937. doi: 10.1021/acs.jcim.7b00564. Epub 2017 Dec 15.
6
Molecular Dynamics in Mixed Solvents Reveals Protein-Ligand Interactions, Improves Docking, and Allows Accurate Binding Free Energy Predictions.混合溶剂中的分子动力学揭示蛋白质-配体相互作用,改善对接,并允许准确预测结合自由能。
J Chem Inf Model. 2017 Apr 24;57(4):846-863. doi: 10.1021/acs.jcim.6b00678. Epub 2017 Mar 31.
7
Molecular dynamics in drug design.药物设计中的分子动力学
Eur J Med Chem. 2015 Feb 16;91:4-14. doi: 10.1016/j.ejmech.2014.08.004. Epub 2014 Aug 4.
8
Latest trends in structure based drug design with protein targets.基于结构的药物设计与蛋白质靶标最新趋势。
Adv Protein Chem Struct Biol. 2020;121:1-23. doi: 10.1016/bs.apcsb.2019.11.008. Epub 2019 Dec 18.
9
Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.通过使用 MM-GBSA 对多个 X 射线蛋白质构象中的配体构象进行重新排序,从而提高对接结果。
J Chem Inf Model. 2014 Oct 27;54(10):2697-717. doi: 10.1021/ci5003735. Epub 2014 Sep 30.
10
CDOCKER and λ-dynamics for prospective prediction in D₃R Grand Challenge 2.CDOCKER 和 λ-动力学在 D₃R 大挑战 2 中的前瞻性预测。
J Comput Aided Mol Des. 2018 Jan;32(1):89-102. doi: 10.1007/s10822-017-0050-5. Epub 2017 Sep 7.

引用本文的文献

1
Molecular chameleons adaptability in target binding.分子变色龙在靶标结合中的适应性。
Struct Dyn. 2025 Aug 13;12(4):044701. doi: 10.1063/4.0000757. eCollection 2025 Jul.
2
Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives.用于肺癌的纳米技术驱动的药物递送系统:计算进展与临床展望。
Thorac Cancer. 2025 Jul;16(14):e70134. doi: 10.1111/1759-7714.70134.
3
DivPro: diverse protein sequence design with direct structure recovery guidance.DivPro:借助直接结构恢复指导进行多样化蛋白质序列设计。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i382-i390. doi: 10.1093/bioinformatics/btaf258.
4
The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials.人工智能在药物创新中的潜力:从药物发现到临床试验
Pharmaceuticals (Basel). 2025 May 25;18(6):788. doi: 10.3390/ph18060788.
5
Bibliometrics Analysis and Knowledge Mapping of Fragment-Based Drug Design Research: Trends from 2015 to 2024.基于片段的药物设计研究的文献计量学分析与知识图谱:2015年至2024年的趋势
Drug Des Devel Ther. 2025 May 22;19:4245-4262. doi: 10.2147/DDDT.S518489. eCollection 2025.
6
A comprehensive review on structural insights through molecular visualization: tools, applications, and limitations.通过分子可视化对结构见解的全面综述:工具、应用及局限性
J Mol Model. 2025 May 27;31(6):173. doi: 10.1007/s00894-025-06402-y.
7
The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.基于肽的抑制剂在破坏蛋白质-蛋白质相互作用以进行靶向癌症治疗中的潜力。
Int J Mol Sci. 2025 Mar 28;26(7):3117. doi: 10.3390/ijms26073117.
8
Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism.毛兰素通过抑制mTOR激活和扰乱嘧啶代谢来抑制肺癌细胞的增殖。
Cancer Biol Med. 2025 Feb 24;22(2):144-65. doi: 10.20892/j.issn.2095-3941.2024.0385.
9
Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis.基于网络药理学和计算机模拟方法揭示艳山姜根茎治疗特发性肺纤维化的多靶点作用机制
F1000Res. 2024 Jun 25;13:216. doi: 10.12688/f1000research.142513.1. eCollection 2024.
10
Linking machine learning and biophysical structural features in drug discovery.在药物发现中连接机器学习与生物物理结构特征
Front Mol Biosci. 2025 Jan 23;11:1305272. doi: 10.3389/fmolb.2024.1305272. eCollection 2024.